KALA

KALA

USD

KALA BIO Inc. Common Stock

$0.751+0.011 (1.527%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.740

High

$0.800

Low

$0.740

Volume

0.08M

Company Fundamentals

Market Cap

5.3M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.11M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.74Current $0.751High $20.6

Related News

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio with a Buy and raises the price target from $12 to $35.

View more
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35
Analyst Upgrades

Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio with a Outperform and raises the price target from $15 to $33.

View more
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33
Analyst Upgrades

Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio with a Outperform rating and announces Price Target of $30.

View more
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30
GlobeNewswire

KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director

ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for

View more
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director